Stay updated with breaking news from Adxn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Addex Therapeutics (NASDAQ:ADXN – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Tuesday, Zacks.com reports. The brokerage presently has a $4.50 target price on the stock. Zacks Investment Research‘s target price would indicate a potential upside of 12.22% from the […]
Addex Therapeutics (NASDAQ:ADXN – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Monday, Zacks.com reports. According to Zacks, “Addex Therapeutics Ltd is a clinical-stage pharmaceutical company. It is focused on the development and commercialization of small molecule drugs for neurological disorders. The […]
Addex Therapeutics Ltd (NASDAQ:ADXN – Get Rating) was the recipient of a large drop in short interest in the month of March. As of March 31st, there was short interest totalling 100 shares, a drop of 50.0% from the March 15th total of 200 shares. Based on an average daily trading volume, of 3,100 shares, […]
Zacks Investment Research upgraded shares of Addex Therapeutics (NASDAQ:ADXN – Get Rating) from a hold rating to a buy rating in a research report sent to investors on Thursday, Zacks.com reports. The firm currently has $5.75 price objective on the stock. According to Zacks, “Addex Therapeutics Ltd is a clinical-stage pharmaceutical company. It is focused […]
Brings total value of contracts up to $5.3m.